Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis

Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis

We present the first case of a male patient with an epidermal growth factor receptor (EGFR) 19del mutation who was diagnosed with intra-abdominal aggressive fibromatosis and familial adenomatous polyposis. We assessed the clinical response of the patient to first-generation EGFR-tyrosine kinase inhi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanjing Guo, Jingjing Wu, Qianming Bai, Juefeng Wan, Qifeng Wang, Xinhong He, Xiaowei Zhang, Zhiguo Luo, Liju Xing, Xin Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Oncology
Subjects:
aggressive fibromatosis
EGFR 19del
targeted therapy
gefitinib
partial response
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1537714/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1537714/full

Similar Items